DH

Daniel Hogan

Director Food Science and Product Development at Nobell Foods

Daniel Hogan has a diverse work experience spanning various scientific roles. Daniel is currently serving as the Director of Food Science and Product Development at Nobell Foods, a position they assumed in April 2023. Prior to that, from February 2020 to April 2023, they worked as a Research Fellow at Impossible Foods.

Before transitioning into the food industry, Hogan gained extensive experience in the field of bioinformatics and research. From February 2014 to February 2020, they were a Bioinformatics Scientist at Tocagen Inc., where they focused on identifying predictive biomarkers and developing diagnostics for glioblastoma multiforme.

Hogan also held positions at Regulus Therapeutics, where they worked as a Scientist, Group Leader Basic Mechanisms Project Team from December 2010 to June 2013. During this time, they contributed to the development of oligonucleotide therapeutics and investigated the mechanism of action of anti-miRs in vivo.

Further back, Hogan pursued their postdoctoral research at Stanford University School of Medicine. Daniel was a Postdoctoral Research Associate from January 2010 to November 2010, where they analyzed DNA microarray data and developed a method to map ribosome-associated chaperone interactions with nascent polypeptides.

Hogan's academic journey began at Stanford University School of Medicine, where they pursued their Ph.D. in Biochemistry from 2002 to 2009. Daniel'sresearch focused on RNA-binding proteins and their regulatory roles in yeast and identified the mRNA targets recruited to Argonuate proteins by specific microRNAs.

Earlier in their career, Hogan was a Fulbright Scholar at the University of Witten/Herdecke from October 2001 to July 2002. Daniel conducted research on macronuclear development in Stylonchia lemnae and proposed the role of PIWI-associated small RNAs in guiding DNA recombination events.

As an undergraduate researcher at the University of Colorado Boulder from August 1998 to August 2001, Hogan developed a method to remove contaminating DNA in stichotrichous ciliates and contributed to the understanding of gene scrambling in these organisms.

Overall, Hogan's work experience showcases their expertise in various scientific disciplines and their contributions to the fields of food science, bioinformatics, and molecular biology.

Daniel Hogan obtained a Bachelor of Science (BS) degree in MCD Biology, Biochemistry with a minor in math from the University of Colorado at Boulder, where they studied from 1998 to 2001. Daniel then pursued their education further at Stanford University School of Medicine from 2002 to 2009 and earned a Phd in Molecular biology, biochemistry, genomics.

Links

Previous companies

Regulus Therapeutics logo